Care During Chemotherapy and Beyond

Acronym: CFAR

Most often associated with treatment of Chronic Lymphocytic Leukemia (CLL).

(Cytoxan®, Neosar®)

Cancers treated with cyclophosphamide include: Hodgkin’s and non-Hodgkin's lymphoma, Burkitt’s lymphoma, chronic lymphocytic leukemia (CLL), chronic myelocytic leukemia (CML), acute myelocytic leukemia (AML), acute lymphocytic leukemia (ALL), t-cell lymphoma (mycosis fungoides), multiple myeloma, neuroblastoma, retinoblastoma, rhabdomyosarcoma, Ewing's sarcoma; breast, testicular, endometrial, ovarian, and lung cancers, and in conditioning regimens for bone marrow transplantation.

Learn More


Treatment of chronic lymphocytic leukemia (CLL), including CLL that has not responded to or reoccurred after standard therapy.

Salvage therapy for non-Hodgkin's lymphoma and acute leukemias.

Learn More


Used to treat B-cell chronic lymphocytic leukemia (CLL)

This drug is administered by infusion into a vein (intravenous, IV).

Alemtuzumab is a monoclonal antibody.

Learn More


Treatment of certain types of non-Hodgkin's lymphoma.

Treatment of chronic lymphocytic leukemia (CLL).

Learn More is designed to provide the latest information about chemotherapy to patients and their families, caregivers and friends. For information about the 4th Angel Mentoring Program visit